691
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics

, , , , , , , , , & show all

References

  • Abbasi, A., A. Aghebati-Maleki, M. Yousefi, and L. Aghebati-Maleki. 2021. Probiotic intervention as a potential therapeutic for managing gestational disorders and improving pregnancy outcomes. Journal of Reproductive Immunology 143:103244. doi: 10.1016/j.jri.2020.103244.
  • Abbasi, A., A. H. Rad, Z. Ghasempour, S. Sabahi, H. S. Kafil, P. Hasannezhad, Y. Rahbar Saadat, and N. Shahbazi. 2022. The biological activities of postbiotics in gastrointestinal disorders. Critical Reviews in Food Science and Nutrition 62 (22):5983–6004. doi: 10.1080/10408398.2021.1895061.
  • Abbasi, A., H. S. Kafil, M. A. Ozma, N. Sangtarash, and S. Sabahi. 2022. Can food matrices be considered as a potential carrier for COVID-19? Le Infezioni in Medicina 30 (1):59.
  • Abbasi, A., L. Aghebati-Maleki, and A. Homayouni-Rad. 2022. The promising biological role of postbiotics derived from probiotic Lactobacillus species in reproductive health. Critical Reviews in Food Science and Nutrition 62 (32):8829–41. doi: 10.1080/10408398.2021.1935701.
  • Abbasi, A., N. Hajipour, P. Hasannezhad, A. Baghbanzadeh, and L. Aghebati-Maleki. 2022. Potential in vivo delivery routes of postbiotics. Critical Reviews in Food Science and Nutrition 62 (12):3345–69. doi: 10.1080/10408398.2020.1865260.
  • Abdelmalek, S. M., and A. Mousa. 2022. Azithromycin misuse during the COVID-19 pandemic: A cross-sectional study from Jordan. Infection and Drug Resistance 15:747–55. doi: 10.2147/IDR.S351827.
  • Aghebati-Maleki, L., P. Hasannezhad, A. Abbasi, and N. Khani. 2021. Antibacterial, antiviral, antioxidant, and anticancer activities of postbiotics: A review of mechanisms and therapeutic perspectives. Biointerface Research in Applied Chemistry 12:2629–45.
  • Ahmed, S., S. A. Sony, M. Chowdhury, M. Ullah, S. Paul, and T. Hossain. 2020. Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside-N-acetyltransferase enzyme by adjuvants: A combination of in-silico and in-vitro study. Scientific Reports 10 (1):1–12. doi: 10.1038/s41598-020-76355-0.
  • Akpinar, A., and O. Yerlikaya. 2021. Some potential beneficial properties of Lacticaseibacillus paracasei subsp. paracasei and Leuconostoc mesenteroides strains originating from raw milk and kefir grains. Journal of Food Processing and Preservation 45 (12):e15986. doi: 10.1111/jfpp.15986.
  • Altunay, B., A. Morgenroth, M. Beheshti, A. Vogg, N. C. L. Wong, H. H. Ting, H.-J. Biersack, E. Stickeler, and F. M. Mottaghy. 2021. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. European Journal of Nuclear Medicine and Molecular Imaging 48 (5):1371–89. doi: 10.1007/s00259-020-05094-1.
  • Aluwong, T., M. Kawu, M. Raji, T. Dzenda, F. Govwang, V. Sinkalu, and J. Ayo. 2013. Effect of yeast probiotic on growth, antioxidant enzyme activities and malondialdehyde concentration of broiler chickens. Antioxidants (Basel, Switzerland) 2 (4):326–39. doi: 10.3390/antiox2040326.
  • Ansari, A., S. Bose, J. K. Patra, N. R. Shin, D.-W. Lim, K.-W. Kim, J.-H. Wang, Y.-M. Kim, Y.-W. Chin, H. Kim, et al. 2018. A controlled fermented Samjunghwan herbal formula ameliorates non-alcoholic hepatosteatosis in HepG2 cells and OLETF rats. Frontiers in Pharmacology 9:596. doi: 10.3389/fphar.2018.00596.
  • Asgharzadeh, M., M. A. Ozma, J. Rashedi, B. M. Poor, V. Agharzadeh, A. Vegari, B. Shokouhi, K. Ganbarov, N. N. Ghalehlou, H. E. Leylabadlo, et al. 2020. False-positive Mycobacterium tuberculosis detection: Ways to prevent cross-contamination. Tuberculosis and Respiratory Diseases 83 (3):211–7. doi: 10.4046/trd.2019.0087.
  • Azami, S., E. Arefian, and N. Kashef. 2022. Postbiotics of Lactobacillus casei target virulence and biofilm formation of Pseudomonas aeruginosa by modulating quorum sensing. Archives of Microbiology 204 (2):1–19. doi: 10.1007/s00203-022-02770-8.
  • Baker, M. T., P. Lu, J. A. Parrella, and H. R. Leggette. 2022. Consumer acceptance toward functional foods: A scoping review. International Journal of Environmental Research and Public Health 19 (3):1217. doi: 10.3390/ijerph19031217.
  • Bamunuarachchi, N. I., F. Khan, and Y.-M. Kim. 2022. Combination therapy for bacterial pathogens: Naturally derived antimicrobial drugs combined with Ulva lactuca extract. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) 22 (1):107–17.
  • Bartolomeu, M., C. Oliveira, C. Pereira, M. G. P. Neves, M. A. F. Faustino, and A. Almeida. 2021. Antimicrobial photodynamic approach in the inactivation of viruses in wastewater: Influence of alternative adjuvants. Antibiotics 10 (7):767. doi: 10.3390/antibiotics10070767.
  • Batinovic, S., F. Wassef, S. A. Knowler, D. T. F. Rice, C. R. Stanton, J. Rose, J. Tucci, T. Nittami, A. Vinh, G. R. Drummond, and C. G. Sobey. 2019. Bacteriophages in natural and artificial environments. Pathogens 8 (3):100. doi: 10.3390/pathogens8030100.
  • Baunwall, S. M. D., E. M. Terveer, J. F. Dahlerup, C. Erikstrup, P. Arkkila, M. J. Vehreschild, G. Ianiro, A. Gasbarrini, H. Sokol, P. K. Kump, et al. 2021. The use of faecal microbiota transplantation (FMT) in Europe: A Europe-wide survey. The Lancet Regional Health. Europe 9:100181. doi: 10.1016/j.lanepe.2021.100181.
  • Bejar, N., T. T. Tat, and D. L. Kiss. 2022. RNA therapeutics: The next generation of drugs for cardiovascular diseases. Current Atherosclerosis Reports 24 (5):307–321. doi: 10.1007/s11883-022-01007-9.
  • Bello-López, J. M., O. A. Cabrero-Martínez, G. Ibáñez-Cervantes, C. Hernández-Cortez, L. I. Pelcastre-Rodríguez, L. U. Gonzalez-Avila, and G. Castro-Escarpulli. 2019. Horizontal gene transfer and its association with antibiotic resistance in the genus Aeromonas spp. Microorganisms 7 (9):363. doi: 10.3390/microorganisms7090363.
  • Berzofsky, J. A., M. Terabe, S. Oh, I. M. Belyakov, J. D. Ahlers, J. E. Janik, and J. C. Morris. 2004. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. The Journal of Clinical Investigation 113 (11):1515–25. doi: 10.1172/JCI21926.
  • Bialvaei, A. Z., H. S. Kafil, M. Asgharzadeh, M. Yousef Memar, and M. Yousefi. 2016. Current methods for the identification of carbapenemases. Journal of Chemotherapy (Florence, Italy) 28 (1):1–19. doi: 10.1179/1973947815Y.0000000063.
  • Blair, J., M. A. Webber, A. J. Baylay, D. O. Ogbolu, and L. J. Piddock. 2015. Molecular mechanisms of antibiotic resistance. Nature Reviews. Microbiology 13 (1):42–51. doi: 10.1038/nrmicro3380.
  • Blaiss, M., J. Maloney, H. Nolte, S. Gawchik, R. Yao, and D. P. Skoner. 2011. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. The Journal of Allergy and Clinical Immunology 127 (1):64–71. e4. doi: 10.1016/j.jaci.2010.11.034.
  • Boo, A., R. L. Amaro, and G.-B. Stan. 2021. Quorum sensing in synthetic biology: A review. Current Opinion in Systems Biology 28:100378. doi: 10.1016/j.coisb.2021.100378.
  • Borthwick, E. M., C. J. Hill, K. S. Rabindranath, A. P. Maxwell, D. F. McAuley, and B. Blackwood; Cochrane Emergency and Critical Care Group. 2017. High‐volume haemofiltration for sepsis in adults. Cochrane Database of Systematic Reviews 2018 (12): CD008075. doi: 10.1002/14651858.CD008075.pub3.
  • Bourdin, G., B. Schmitt, L. Marvin Guy, J.-E. Germond, S. Zuber, L. Michot, G. Reuteler, and H. Brüssow. 2014. Amplification and purification of T4-like Escherichia coli phages for phage therapy: From laboratory to pilot scale. Applied and Environmental Microbiology 80 (4):1469–76. doi: 10.1128/AEM.03357-13.
  • Bueno, J. 2016. Antimicrobial adjuvants drug discovery, the challenge of avoid the resistance and recover the susceptibility of multidrug-resistant strains. Journal of Microbial & Biochemical Technology 8 (3):169–76. doi: 10.4172/1948-5948.1000281.
  • Cabello-Olmo, M., M. Araña, R. Urtasun, I. J. Encio, and M. Barajas. 2021. Role of postbiotics in diabetes mellitus: Current knowledge and future perspectives. Foods 10 (7):1590. doi: 10.3390/foods10071590.
  • Case, R. J., M. Labbate, and S. Kjelleberg. 2008. AHL-driven quorum-sensing circuits: Their frequency and function among the Proteobacteria. The ISME Journal 2 (4):345–9. doi: 10.1038/ismej.2008.13.
  • Catalano, A., D. Iacopetta, J. Ceramella, D. Scumaci, F. Giuzio, C. Saturnino, S. Aquaro, C. Rosano, and M. S. Sinicropi. 2022. Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies. Molecules 27 (3):616. doi: 10.3390/molecules27030616.
  • Cavallari, J. F., N. G. Barra, K. P. Foley, A. Lee, B. M. Duggan, B. D. Henriksbo, F. F. Anhê, A. A. Ashkar, and J. D. Schertzer. 2020. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice. American Journal of Physiology, Endocrinology and Metabolism 318 (4):E579–E585. doi: 10.1152/ajpendo.00033.2020.
  • Chadha, J., K. Harjai, and S. Chhibber. 2022. Revisiting the virulence hallmarks of Pseudomonas aeruginosa: A chronicle through the perspective of quorum sensing. Environmental Microbiology 24 (6):2630–56. doi: 10.1111/1462-2920.15784.
  • Chan, B. K., S. T. Abedon, and C. Loc-Carrillo. 2013. Phage cocktails and the future of phage therapy. Future Microbiology 8 (6):769–83. doi: 10.2217/fmb.13.47.
  • Chen, W., Y. Yuan, and X. Jiang. 2020. Antibody and antibody fragments for cancer immunotherapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 328:395–406. doi: 10.1016/j.jconrel.2020.08.021.
  • Chen, Y.-C., Y.-J. Wu, and C.-Y. Hu. 2019. Monosaccharide composition influence and immunomodulatory effects of probiotic exopolysaccharides. International Journal of Biological Macromolecules 133:575–82. doi: 10.1016/j.ijbiomac.2019.04.109.
  • Chen, Z., Y. Hu, L. Jin, F. Yang, H. Ding, L. Zhang, L. Li, and T. Pan. 2022. The emerging role of N6-methyladenosine RNA methylation as regulators in cancer therapy and drug resistance. Frontiers in Pharmacology 13:873030. doi: 10.3389/fphar.2022.873030.
  • Choi, S., M-g Baek, M.-J. Chung, S. Lim, and H. Yi. 2021. Distribution of bacteriocin genes in the lineages of Lactiplantibacillus plantarum. Scientific Reports 11 (1):1–10. doi: 10.1038/s41598-021-99683-1.
  • Cisek, A. A., I. Dąbrowska, K. P. Gregorczyk, and Z. Wyżewski. 2017. Phage therapy in bacterial infections treatment: One hundred years after the discovery of bacteriophages. Current Microbiology 74 (2):277–83. doi: 10.1007/s00284-016-1166-x.
  • Conte, M., M. Porpora, F. Nigro, R. Nigro, A. L. Budelli, M. V. Barone, and M. Nanayakkara. 2021. Pro-pre and postbiotic in celiac disease. Applied Sciences 11 (17):8185. doi: 10.3390/app11178185.
  • Cuevas-González, P., A. Liceaga, and J. Aguilar-Toalá. 2020. Postbiotics and paraprobiotics: From concepts to applications. Food Research International (Ottawa, Ont.) 136:109502. doi: 10.1016/j.foodres.2020.109502.
  • D’Accolti, M., I. Soffritti, S. Mazzacane, and E. Caselli. 2021. Bacteriophages as a potential 360-degree pathogen control strategy. Microorganisms 9 (2):261. doi: 10.3390/microorganisms9020261.
  • D’Amico, D., P. A. Andreux, P. Valdés, A. Singh, C. Rinsch, and J. Auwerx. 2021. Impact of the natural compound urolithin A on health, disease, and aging. Trends in Molecular Medicine 27 (7):687–99. doi: 10.1016/j.molmed.2021.04.009.
  • Darwish, M. S., L. Qiu, M. A. Taher, A. A. Zaki, N. A. Abou-Zeid, D. H. Dawood, O. M. A. K. Shalabi, E. Khojah, and A. A. Elawady. 2022. Health benefits of postbiotics produced by E. coli Nissle 1917 in functional yogurt enriched with cape gooseberry (Physalis peruviana L.). Fermentation 8 (3):128. doi: 10.3390/fermentation8030128.
  • Das, B., J. Bischerour, and F.-X. Barre. 2011. VGJɸ integration and excision mechanisms contribute to the genetic diversity of Vibrio cholerae epidemic strains. Proceedings of the National Academy of Sciences of the United States of America 108 (6):2516–21. doi: 10.1073/pnas.1017061108.
  • de Carvalho, F. R. T., J. P. Telles, F. F. B. Tuon, R. Rabello Filho, P. Caruso, and T. D. Correa. 2022. Antimicrobial stewardship programs: A review of strategies to avoid polymyxins and carbapenems misuse in low middle-income countries. Antibiotics 11 (3):378. doi: 10.3390/antibiotics11030378.
  • Defoirdt, T., G. Brackman, and T. Coenye. 2013. Quorum sensing inhibitors: How strong is the evidence? Trends in Microbiology 21 (12):619–24. doi: 10.1016/j.tim.2013.09.006.
  • Delany, I., R. Rappuoli, and K. L. Seib. 2013. Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harbor Perspectives in Medicine 3 (5):a012476. doi: 10.1101/cshperspect.a012476.
  • Deyab, M., T. Elkatony, and F. Ward. 2016. Qualitative and quantitative analysis of phytochemical studies on brown seaweed, Dictyota dichotoma. International Journal of Engineering Development and Research 4 (2):674–8.
  • Diago-Navarro, E., I. Calatayud-Baselga, D. Sun, C. Khairallah, I. Mann, A. Ulacia-Hernando, B. Sheridan, M. Shi, and B. C. Fries. 2017. Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clinical and Vaccine Immunology 24 (1): E 00456–16. doi: 10.1128/CVI.00456-16.
  • Domingo‐Calap, P., P. Georgel, and S. Bahram. 2016. Back to the future: Bacteriophages as promising therapeutic tools. HLA 87 (3):133–40. doi: 10.1111/tan.12742.
  • Dong, Y.-H., and L.-H. Zhang. 2005. Quorum sensing and quorum-quenching enzymes. Journal of Microbiology 43 (spc1):101–9.
  • Duan, Y., R. Young, and B. Schnabl. 2022. Bacteriophages and their potential for treatment of gastrointestinal diseases. Nature Reviews. Gastroenterology & Hepatology 19 (2):135–44. doi: 10.1038/s41575-021-00536-z.
  • Duan, Z., and Y. Luo. 2021. Targeting macrophages in cancer immunotherapy. Signal Transduction and Targeted Therapy 6 (1):1–21. doi: 10.1038/s41392-021-00506-6.
  • Durães, F., N. Szemerédi, D. Kumla, M. Pinto, A. Kijjoa, G. Spengler, and E. Sousa. 2021. Metabolites from marine-derived fungi as potential antimicrobial adjuvants. Marine Drugs 19 (9):475. doi: 10.3390/md19090475.
  • Dykxhoorn, D. M., and J. Lieberman. 2005. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annual Review of Medicine 56:401–23. doi: 10.1146/annurev.med.56.082103.104606.
  • Edgar, R., N. Friedman, S. Molshanski-Mor, and U. Qimron. 2012. Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Applied and Environmental Microbiology 78 (3):744–51. doi: 10.1128/AEM.05741-11.
  • Ekwochi, U., J. M. Chinawa, I. Obi, H. A. Obu, and S. Agwu. 2013. Use and/or misuse of antibiotics in management of diarrhea among children in Enugu, Southeast Nigeria. Journal of Tropical Pediatrics 59 (4):314–6. doi: 10.1093/tropej/fmt016.
  • Elkrief, A., and B. Routy. 2021. First clinical proof-of-concept that FMT can overcome resistance to ICIs. Nature Reviews. Clinical Oncology 18 (6):325–6. doi: 10.1038/s41571-021-00502-3.
  • Fathima, S., R. Shanmugasundaram, D. Adams, and R. K. Selvaraj. 2022. Gastrointestinal microbiota and their manipulation for improved growth and performance in chickens. Foods 11 (10):1401. doi: 10.3390/foods11101401.
  • Ferdows, B. E., D. N. Patel, W. Chen, X. Huang, N. Kong, and W. Tao. 2022. RNA cancer nanomedicine: Nanotechnology-mediated RNA therapy. Nanoscale 14 (12):4448–55. doi: 10.1039/d1nr06991h.
  • Fortman, J. L., and A. Mukhopadhyay. 2016. The future of antibiotics: Emerging technologies and stewardship. Trends in Microbiology 24 (7):515–7. doi: 10.1016/j.tim.2016.04.003.
  • France, M., M. Alizadeh, S. Brown, B. Ma, and J. Ravel. 2022. Towards a deeper understanding of the vaginal microbiota. Nature Microbiology 7 (3):367–78. doi: 10.1038/s41564-022-01083-2.
  • Freeland, D. M. H., M. Manohar, S. Andorf, B. D. Hobson, W. Zhang, and K. C. Nadeau, editors. 2017. Oral immunotherapy for food allergy. In Seminars in immunology; vol. 30, 36–44. Elsevier. doi: 10.1016/j.smim.2017.08.008.
  • Fu, J., L.-L. Zhang, W. Li, Y. Zhang, Y. Zhang, F. Liu, and L. Zou. 2022. Application of metabolomics for revealing the interventional effects of functional foods on metabolic diseases. Food Chemistry 367:130697. doi: 10.1016/j.foodchem.2021.130697.
  • Galloway, W. R., J. T. Hodgkinson, S. D. Bowden, M. Welch, and D. R. Spring. 2011. Quorum sensing in Gram-negative bacteria: Small-molecule modulation of AHL and AI-2 quorum sensing pathways. Chemical Reviews 111 (1):28–67. doi: 10.1021/cr100109t.
  • Gao, Y., X. Wang, C. Xue, and Z. Wei. 2021. Latest developments in food-grade delivery systems for probiotics: A systematic review. Critical Reviews in Food Science and Nutrition :1–18. doi: 10.1080/10408398.2021.2001640.
  • Gholizadeh, P., M. Mahallei, A. Pormohammad, M. Varshochi, K. Ganbarov, E. Zeinalzadeh, B. Yousefi, M. Bastami, A. Tanomand, S. S. Mahmood, et al. 2019. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. Microbial Pathogenesis 127:48–55. doi: 10.1016/j.micpath.2018.11.031.
  • Ghosh, S., B. Sarkar, A. Kaushik, and E. Mostafavi. 2022. Nanobiotechnological prospects of probiotic microflora: Synthesis, mechanism, and applications. The Science of the Total Environment 838 (Pt 3):156212. doi: 10.1016/j.scitotenv.2022.156212.
  • Gill, E. E., O. L. Franco, and R. E. Hancock. 2015. Antibiotic adjuvants: Diverse strategies for controlling drug‐resistant pathogens. Chemical Biology & Drug Design 85 (1):56–78. doi: 10.1111/cbdd.12478.
  • Golkar, N., Y. Ashoori, R. Heidari, N. Omidifar, S. N. Abootalebi, M. Mohkam, and A. Gholami. 2021. A novel effective formulation of bioactive compounds for wound healing: Preparation, in vivo characterization, and comparison of various postbiotics cold creams in a rat model. Evidence-Based Complementary and Alternative Medicine 2021:1–13. doi: 10.1155/2021/8577116.
  • Gordillo Altamirano, F. L., and J. J. Barr. 2019. Phage therapy in the postantibiotic era. Clinical Microbiology Reviews 32 (2): E 00066–18. doi: 10.1128/CMR.00066-18.
  • Granato, D. 2022. Functional foods to counterbalance low-grade ­inflammation and oxidative stress in cardiovascular diseases: A multi-layered strategy combining food and health sciences. Current Opinion in Food Science 47:100894. doi: 10.1016/j.cofs.2022.100894.
  • Gullett, N. P., A. R. Amin, S. Bayraktar, J. M. Pezzuto, D. M. Shin, F. R. Khuri, et al. editors. 2010. Cancer prevention with natural compounds. Seminars in oncology 37:258–81. Elsevier. doi: 10.1053/j.seminoncol.2010.06.014.
  • Gupta, P. D., and T. J. Birdi. 2017. Development of botanicals to combat antibiotic resistance. Journal of Ayurveda and Integrative Medicine 8 (4):266–75. doi: 10.1016/j.jaim.2017.05.004.
  • Hadinoto, K., and W. S. Cheow. 2014. Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa. Colloids and Surfaces. B, Biointerfaces 116:772–85. doi: 10.1016/j.colsurfb.2014.02.032.
  • Hasan, M., P. P. Ghosh, K. F. Azim, S. Mukta, R. A. Abir, J. Nahar, and M. M. Hasan Khan. 2019. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus. Microbial Pathogenesis 130:19–37. doi: 10.1016/j.micpath.2019.02.023.
  • Hatfull, G. F., R. M. Dedrick, and R. T. Schooley. 2022. Phage therapy for antibiotic-resistant bacterial infections. Annual Review of Medicine 73:197–211. doi: 10.1146/annurev-med-080219-122208.
  • Hegazy, M., O. Ahmed Ashoush, M. Tharwat Hegazy, M. Wahba, R. M. Lithy, H. M. Abdel-Hamid, S. Ahmed Abd Elshafy, D. Abdelfatah, M. H. El-Din Ibrahim, A. Abdelghani, et al. 2022. Beyond probiotic legend: ESSAP gut microbiota health score to delineate SARS-COV-2 infection severity. The British Journal of Nutrition 127 (8):1180–9. doi: 10.1017/S0007114521001926.
  • Hemmati, F., R. Salehi, R. Ghotaslou, H. Samadi Kafil, A. Hasani, P. Gholizadeh, R. Nouri, and M. Ahangarzadeh Rezaee. 2020. Quorum quenching: A potential target for antipseudomonal therapy. Infection and Drug Resistance 13:2989–3005. doi: 10.2147/IDR.S263196.
  • Henderson, P. J., C. Maher, L. D. Elbourne, B. A. Eijkelkamp, I. T. Paulsen, and K. A. Hassan. 2021. Physiological functions of bacterial “multidrug” efflux pumps. Chemical Reviews 121 (9):5417–78. doi: 10.1021/acs.chemrev.0c01226.
  • Herencias, C., S. Salgado-Briegas, and M. A. Prieto. 2020. Emerging horizons for industrial applications of predatory bacteria. In The Ecology of Predation at the Microscale, eds. Jurkevitch, E., Mitchell, R., 173–94. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-45599-6_7.
  • Hernández-Granados, M. J., and E. Franco-Robles. 2020. Postbiotics in human health: Possible new functional ingredients? Food Research International (Ottawa, Ont.) 137:109660. doi: 10.1016/j.foodres.2020.109660.
  • Hmelo, L. R. 2017. Quorum sensing in marine microbial environments. Annual Review of Marine Science 9:257–81. doi: 10.1146/annurev-marine-010816-060656.
  • Hobbs, Z., and S. T. Abedon. 2016. Diversity of phage infection types and associated terminology: The problem with ‘Lytic or lysogenic. FEMS Microbiology Letters 363 (7):fnw047. doi: 10.1093/femsle/fnw047.
  • Holmes, A. H., L. S. P. Moore, A. Sundsfjord, M. Steinbakk, S. Regmi, A. Karkey, P. J. Guerin, and L. J. V. Piddock. 2016. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet (London, England) 387 (10014):176–87. doi: 10.1016/S0140-6736(15)00473-0.
  • Homayouni Rad, A., L. Aghebati Maleki, H. Samadi Kafil, and A. Abbasi. 2021. Postbiotics: A novel strategy in food allergy treatment. Critical Reviews in Food Science and Nutrition 61 (3):492–9. doi: 10.1080/10408398.2020.1738333.
  • Huang, C., M. Li, C. Chen, and Q. Yao. 2008. Small interfering RNA therapy in cancer: Mechanism, potential targets, and clinical applications. Expert Opinion on Therapeutic Targets 12 (5):637–45. doi: 10.1517/14728222.12.5.637.
  • Hulscher, M. E., J. W. van der Meer, and R. P. Grol. 2010. Antibiotic use: How to improve it? International Journal of Medical Microbiology: IJMM 300 (6):351–6. doi: 10.1016/j.ijmm.2010.04.003.
  • Hussien, Z. G., and R. A. Aziz. 2021. Chemical composition and antibacterial activity of Linum usitatissimum L. (Flaxseed). Systematic Reviews in Pharmacy 12 (2):145–7.
  • Ibraheem, D. R., N. N. Hussein, G. M. Sulaiman, H. A. Mohammed, R. A. Khan, and O. Al Rugaie. 2022. Ciprofloxacin-loaded silver nanoparticles as potent nano-antibiotics against resistant pathogenic bacteria. Nanomaterials 12 (16):2808. doi: 10.3390/nano12162808.
  • Iglesias-Aguirre, C. E., A. Cortés-Martín, M. Á. Ávila-Gálvez, J. A. Giménez-Bastida, M. V. Selma, A. González-Sarrías, and J. C. Espín. 2021. Main drivers of (poly) phenol effects on human health: Metabolite production and/or gut microbiota-associated metabotypes? Food & Function 12 (21):10324–55. doi: 10.1039/d1fo02033a.
  • Ismail, S., S. Ahmad, and S. S. Azam. 2020. Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 146:105258. doi: 10.1016/j.ejps.2020.105258.
  • Izuddin, W. I., A. M. Humam, T. C. Loh, H. L. Foo, and A. A. Samsudin. 2020. Dietary postbiotic Lactobacillus plantarum improves serum and ruminal antioxidant activity and upregulates hepatic antioxidant enzymes and ruminal barrier function in post-weaning lambs. Antioxidants 9 (3):250. doi: 10.3390/antiox9030250.
  • Jahantigh, H. R., S. Faezi, M. Habibi, M. Mahdavi, A. Stufano, P. Lovreglio, and K. Ahmadi. 2022. The candidate antigens to achieving an effective vaccine against Staphylococcus aureus. Vaccines 10 (2):199. doi: 10.3390/vaccines10020199.
  • Kadouri, D. E., K. To, R. M. Q. Shanks, and Y. Doi. 2013. Predatory bacteria: A potential ally against multidrug-resistant Gram-negative pathogens. PloS One 8 (5):e63397. doi: 10.1371/journal.pone.0063397.
  • Kalashgarani, M. Y., and A. Babapoor. 2022. Application of nano-antibiotics in the diagnosis and treatment of infectious diseases. Advances in Applied NanoBio-Technologies 3 (1):22–35.
  • Kalia, V. C. 2013. Quorum sensing inhibitors: An overview. Biotechnology Advances 31 (2):224–45. doi: 10.1016/j.biotechadv.2012.10.004.
  • Kaur, H., S. Golovko, M. Y. Golovko, S. Singh, D. C. Darland, and C. K. Combs. 2020. Effects of probiotic supplementation on short chain fatty acids in the App NL-GF mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease : JAD 76 (3):1083–102. doi: 10.3233/JAD-200436.
  • Khani, N., R. Abedi Soleimani, G. Noorkhajavi, A. Abedi Soleimani, A. Abbasi, and A. Homayouni Rad. 2022. Postbiotics as potential promising tools for SARS‐CoV‐2 disease adjuvant therapy. Journal of Applied Microbiology 132 (6):4097–111. doi: 10.1111/jam.15457.
  • Khare, T., U. Anand, A. Dey, Y. G. Assaraf, Z.-S. Chen, Z. Liu, and V. Kumar. 2021. Exploring phytochemicals for combating antibiotic resistance in microbial pathogens. Frontiers in Pharmacology 12:720726. doi: 10.3389/fphar.2021.720726.
  • Kim, H. K., N. B. M. M. Rutten, I. Besseling-van der Vaart, L. E. M. Niers, Y. H. Choi, G. T. Rijkers, and S. van Hemert. 2015. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Beneficial Microbes 6 (6):783–90. doi: 10.3920/BM2015.0056.
  • Kim, W.-J., J.-H. Hyun, N.-K. Lee, and H.-D. Paik. 2022. Protective effects of a novel Lactobacillus brevis strain with probiotic characteristics against Staphylococcus aureus lipoteichoic acid-induced intestinal inflammatory response. Journal of Microbiology and Biotechnology 32 (2):205–11. doi: 10.4014/jmb.2110.10034.
  • Kirtonia, K., M. Salauddin, K. K. Bharadwaj, S. Pati, A. Dey, M. A. Shariati, V. K. Tilak, E. Kuznetsova, and T. Sarkar. 2021. Bacteriocin: A new strategic antibiofilm agent in food industries. Biocatalysis and Agricultural Biotechnology 36:102141. doi: 10.1016/j.bcab.2021.102141.
  • Korp, J., M. S. V. Gurovic, and M. Nett. 2016. Antibiotics from predatory bacteria. Beilstein Journal of Organic Chemistry 12 (1):594–607. doi: 10.3762/bjoc.12.58.
  • Kortright, K. E., B. K. Chan, J. L. Koff, and P. E. Turner. 2019. Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host & Microbe 25 (2):219–32. doi: 10.1016/j.chom.2019.01.014.
  • Kourkoutas, Y., K. A. Karatzas, V. P. Valdramidis, and N. Chorianopoulos. 2015. Bioactive natural products: Facts, applications, and challenges. BioMed Research International 2015:1–2. doi: 10.1155/2015/684109.
  • Kumar, S. B., S. R. Arnipalli, and O. Ziouzenkova. 2020. Antibiotics in food chain: The consequences for antibiotic resistance. Antibiotics 9 (10):688. doi: 10.3390/antibiotics9100688.
  • Kumar, S., M. Lekshmi, A. Parvathi, M. Ojha, N. Wenzel, and M. F. Varela. 2020. Functional and structural roles of the major facilitator superfamily bacterial multidrug efflux pumps. Microorganisms 8 (2):266. doi: 10.3390/microorganisms8020266.
  • Kumar, V., B. Naik, A. Kumar, N. Khanduri, S. Rustagi, and S. Kumar. 2022. Probiotics media: Significance, challenges, and future perspective-a mini review. Food Production, Processing and Nutrition 4 (1):1–13. doi: 10.1186/s43014-022-00098-w.
  • Kutter, E., D. De Vos, G. Gvasalia, Z. Alavidze, L. Gogokhia, S. Kuhl, and S. T. Abedon. 2010. Phage therapy in clinical practice: Treatment of human infections. Current Pharmaceutical Biotechnology 11 (1):69–86. doi: 10.2174/138920110790725401.
  • Lamut, A., L. Peterlin Mašič, D. Kikelj, and T. Tomašič. 2019. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Medicinal Research Reviews 39 (6):2460–504. doi: 10.1002/med.21591.
  • Larsson, D., and C.-F. Flach. 2022. Antibiotic resistance in the environment. Nature Reviews. Microbiology 20 (5):257–69. doi: 10.1038/s41579-021-00649-x.
  • Larsson, L., C. Garaicoa‐Pazmino, F. Asa’ad, and R. M. Castilho. 2022. Understanding the role of endotoxin tolerance in chronic inflammatory conditions and periodontal disease. Journal of Clinical Periodontology 49 (3):270–9. doi: 10.1111/jcpe.13591.
  • LeBlanc, J. G., F. Chain, R. Martín, L. G. Bermúdez-Humarán, S. Courau, and P. Langella. 2017. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microbial Cell Factories 16 (1):1–10. doi: 10.1186/s12934-017-0691-z.
  • Li, H.-Y., D.-D. Zhou, R.-Y. Gan, S.-Y. Huang, C.-N. Zhao, A. Shang, X.-Y. Xu, and H.-B. Li. 2021. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients 13 (9):3211. doi: 10.3390/nu13093211.
  • Li, J., Y. Zhang, X. Wang, S. T. Walk, and G. Wang. 2021. Integrated metabolomics and targeted gene transcription analysis reveal global bacterial antimonite resistance mechanisms. Frontiers in Microbiology 12:617050. doi: 10.3389/fmicb.2021.617050.
  • Li, R., F. Xiao, X. Zheng, H. Yang, L. Wang, D. Yin, T. Yin, Q. Xin, and B. Chen. 2016. Antibiotic misuse among children with diarrhea in China: Results from a national survey. PeerJ. 4:e2668. doi: 10.7717/peerj.2668.
  • Lin, S.-R., C.-H. Chang, C.-F. Hsu, M.-J. Tsai, H. Cheng, M. K. Leong, P.-J. Sung, J.-C. Chen, and C.-F. Weng. 2020. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. British Journal of Pharmacology 177 (6):1409–23. doi: 10.1111/bph.14816.
  • Liu, M., B. Acres, J.-M. Balloul, N. Bizouarne, S. Paul, P. Slos, and P. Squiban. 2004. Gene-based vaccines and immunotherapeutics. Proceedings of the National Academy of Sciences 101 (suppl_2):14567–71. doi: 10.1073/pnas.0404845101.
  • Liu, S., Y. Zhao, X. Feng, and H. Xu. 2022. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies. Critical Reviews in Food Science and Nutrition :1–19. doi: 10.1080/10408398.2022.2103090.
  • Liu, X., B. Mao, J. Gu, J. Wu, S. Cui, G. Wang, J. Zhao, H. Zhang, and W. Chen. 2021. Blautia—A new functional genus with potential probiotic properties? Gut Microbes 13 (1):1–21. doi: 10.1080/19490976.2021.1875796.
  • Liu, Y., X. Chen, D. Wang, H. Li, J. Huang, Z. Zhang, Y. Qiao, H. Zhang, Y. Zeng, C. Tang, et al. 2018. Hemofiltration successfully eliminates severe cytokine release syndrome following CD19 CAR-T-cell therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997) 41 (9):406–10. doi: 10.1097/CJI.0000000000000243.
  • Loc-Carrillo, C., and S. T. Abedon. 2011. Pros and cons of phage therapy. Bacteriophage 1 (2):111–4. doi: 10.4161/bact.1.2.14590.
  • Maamouri, O., and M. Ben Salem. 2022. The effect of live yeast Saccharomyces cerevisiae as probiotic supply on growth performance, feed intake, ruminal pH and fermentation in fattening calves. Veterinary Medicine and Science 8 (1):398–404. doi: 10.1002/vms3.631.
  • Magalhães, J., N. Franko, S. Raboni, G. Annunziato, P. Tammela, A. Bruno, S. Bettati, A. Mozzarelli, M. Pieroni, B. Campanini, et al. 2020. Inhibition of nonessential bacterial targets: Discovery of a novel serine O-acetyltransferase inhibitor. ACS Medicinal Chemistry Letters 11 (5):790–7. doi: 10.1021/acsmedchemlett.9b00627.
  • Malagón-Rojas, J. N., A. Mantziari, S. Salminen, and H. Szajewska. 2020. Postbiotics for preventing and treating common infectious diseases in children: A systematic review. Nutrients 12 (2):389. doi: 10.3390/nu12020389.
  • Mammari, N., Y. Krier, Q. Albert, M. Devocelle, and M. Varbanov; OEMONOM. 2021. Plant-derived antimicrobial peptides as potential antiviral agents in systemic viral infections. Pharmaceuticals 14 (8):774. doi: 10.3390/ph14080774.
  • Manassi, C. F., S. S. de Souza, G. d S. Hassemer, S. Sartor, C. M. G. Lima, M. Miotto, J. De Dea Lindner, K. Rezzadori, T. C. Pimentel, G. L. d P. A. Ramos, et al. 2022. Functional meat products: Trends in pro-, pre-, syn-, para-and post-biotic use. Food Research International (Ottawa, Ont.) 154:111035. doi: 10.1016/j.foodres.2022.111035.
  • Mantziari, A., S. Salminen, H. Szajewska, and J. N. Malagón-Rojas. 2020. Postbiotics against pathogens commonly involved in pediatric infectious diseases. Microorganisms 8 (10):1510. doi: 10.3390/microorganisms8101510.
  • Maree, M., L. T. Thi Nguyen, R. L. Ohniwa, M. Higashide, T. Msadek, and K. Morikawa. 2022. Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms. Nature Communications 13 (1):1–14. doi: 10.1038/s41467-022-29877-2.
  • Martinez de Tejada, B. 2014. Antibiotic use and misuse during pregnancy and delivery: Benefits and risks. International Journal of Environmental Research and Public Health 11 (8):7993–8009. doi: 10.3390/ijerph110807993.
  • Massoud, R., and A. Zoghi. 2022. Potential probiotic strains with heavy metals and mycotoxins bioremoval capacity for application in foodstuffs. Journal of Applied Microbiology 133 (3):1288–307. doi: 10.1111/jam.15685.
  • Matos, M. S., J. D. Anastácio, and C. Nunes dos Santos. 2021. Sesquiterpene lactones: Promising natural compounds to fight inflammation. Pharmaceutics 13 (7):991. doi: 10.3390/pharmaceutics13070991.
  • Matzov, D., A. Bashan, and A. Yonath. 2017. A bright future for antibiotics? Annual Review of Biochemistry 86:567–83. doi: 10.1146/annurev-biochem-061516-044617.
  • Mayorgas, A., I. Dotti, and A. Salas. 2021. Microbial metabolites, postbiotics, and intestinal epithelial function. Molecular Nutrition & Food Research 65 (5):2000188. doi: 10.1002/mnfr.202000188.
  • Meric-Bernstam, F., J. Larkin, J. Tabernero, and C. Bonini. 2021. Enhancing anti-tumour efficacy with immunotherapy combinations. Lancet (London, England) 397 (10278):1010–22. doi: 10.1016/S0140-6736(20)32598-8.
  • Miao, M., W.-Q. Yu, Y. Li, Y.-L. Sun, and S.-D. Guo. 2022. Structural elucidation and activities of Cordyceps militaris-derived polysaccharides: A review. Frontiers in Nutrition 9:898674. doi: 10.3389/fnut.2022.898674.
  • Minj, J., P. Chandra, C. Paul, and R. K. Sharma. 2021. Bio-functional properties of probiotic Lactobacillus: Current applications and research perspectives. Critical Reviews in Food Science and Nutrition 61 (13):2207–24. doi: 10.1080/10408398.2020.1774496.
  • Mir, C., Y. Garcia-Mayea, andM. E. LLeonart. 2022. Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy. Seminars in Cancer Biology 86 (Pt 3):69–83. doi: 10.1016/j.semcancer.2022.06.008. 35772609
  • Mirzaei, S., M. K. Mahabady, A. Zabolian, A. Abbaspour, P. Fallahzadeh, M. Noori, F. Hashemi, K. Hushmandi, S. Daneshi, A. P. Kumar, et al. 2021. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems. Life Sciences 275:119368. doi: 10.1016/j.lfs.2021.119368.
  • Modi, S., G. K. Inwati, A. Gacem, S. Saquib Abullais, R. Prajapati, V. K. Yadav, R. Syed, M. S. Alqahtani, K. K. Yadav, S. Islam, et al. 2022. Nanostructured antibiotics and their emerging medicinal applications: An overview of nanoantibiotics. Antibiotics 11 (6):708. doi: 10.3390/antibiotics11060708.
  • Monnappa, A. K., W. Bari, S. Y. Choi, and R. J. Mitchell. 2016. Investigating the responses of human epithelial cells to predatory bacteria. Scientific Reports 6 (1):1–14. doi: 10.1038/srep33485.
  • Nagpal, R., S. Wang, S. Ahmadi, J. Hayes, J. Gagliano, S. Subashchandrabose, D. W. Kitzman, T. Becton, R. Read, H. Yadav, et al. 2018. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Scientific Reports 8 (1):1–15. doi: 10.1038/s41598-018-30114-4.
  • Nakatsu, G. 2022. Toward a postbiotic era of microbiome science: Opportunities to advance immunotherapies for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 37 (1):34–8. doi: 10.1111/jgh.15715.
  • Nam, G. H., Y. Choi, G. B. Kim, S. Kim, S. A. Kim, and I. S. Kim. 2020. Emerging prospects of exosomes for cancer treatment: From conventional therapy to immunotherapy. Advanced Materials 32 (51):2002440. doi: 10.1002/adma.202002440.
  • Nayebi, A., J. G. Navashenaq, D. Soleimani, and S. M. Nachvak. 2022. Probiotic supplementation: A prospective approach in the treatment of COVID-19. Nutrition and Health 28 (2):163–75. doi: 10.1177/02601060211049631.
  • Neag, M. A., A. Catinean, D. M. Muntean, M. R. Pop, C. I. Bocsan, E. C. Botan, and A. D. Buzoianu. 2020. Probiotic Bacillus spores protect against acetaminophen induced acute liver injury in rats. Nutrients 12 (3):632. doi: 10.3390/nu12030632.
  • Nguyen, P.-T., T.-T. Nguyen, D.-C. Bui, P.-T. Hong, Q.-K. Hoang, and H.-T. Nguyen. 2020. Exopolysaccharide production by lactic acid bacteria: The manipulation of environmental stresses for industrial applications. AIMS Microbiology 6 (4):451–69. doi: 10.3934/microbiol.2020027.
  • Nocerino, R., L. Paparo, G. Terrin, V. Pezzella, A. Amoroso, L. Cosenza, G. Cecere, G. De Marco, M. Micillo, F. Albano, et al. 2017. Cow’s milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: A randomized controlled trial. Clinical Nutrition (Edinburgh, Scotland) 36 (1):118–25. doi: 10.1016/j.clnu.2015.12.004.
  • Nourizadeh, R., B. Sepehri, A. Abbasi, R. Sayyed, and L. Khalili. 2022. Impact of probiotics in modulation of gut microbiome. In Microbiome-gut-brain axis, 401–9. Singapore: Springer.
  • Nurzaman, M., S. A. Abadi, T. Setiawati, and A. Z. Mutaqin, editors. Characterization of the phytochemical and chlorophyll content as well as the morphology and anatomy of the Rhizophoraceae family in the mangrove forest in Bulaksetra, Pangandaran. AIP conference proceedings; 2018. AIP Publishing LLC. Singapore: Springer
  • O’Hara, A. M., and F. Shanahan. 2007. Mechanisms of action of probiotics in intestinal diseases. The Scientific World Journal 7:31–46. doi: 10.1100/tsw.2007.26.
  • Osman, A., N. El-Gazzar, T. N. Almanaa, A. El-Hadary, and M. Sitohy. 2021. Lipolytic postbiotic from Lactobacillus paracasei manages metabolic syndrome in albino wistar rats. Molecules 26 (2):472. doi: 10.3390/molecules26020472.
  • Ozma, M. A., A. Abbasi, and S. Sabahi. 2022. Characterization of postbiotics derived from Lactobacillus paracasei ATCC 55544 and its application in Malva sylvestris seed mucilage edible coating to the improvement of the microbiological, and sensory properties of lamb meat during storage.
  • Ozma, M. A., A. Abbasi, M. Ahangarzadeh Rezaee, H. Hosseini, N. Hosseinzadeh, S. Sabahi, S. M. A. Noori, S. Sepordeh, E. Khodadadi, M. Lahouty, et al. 2022. A critical review on the nutritional and medicinal profiles of garlic’s (Allium sativum L.) bioactive compounds. Food Reviews International :1–38. doi: 10.1080/87559129.2022.2100417.
  • Ozma, M. A., A. Abbasi, M. Asgharzadeh, P. Pagliano, A. Guarino, Ş. Köse, and H. Samadi Kafil. 2022. Antibiotic therapy for pan-drug-resistant infections. Le Infezioni in Medicina 30 (4):525.
  • Ozma, M. A., A. Abbasi, S. Akrami, M. Lahouty, N. Shahbazi, K. Ganbarov, et al. 2022. Postbiotics as the key mediators of the gut microbiota-host interactions. Le Infezioni in Medicina 30 (2):180.
  • Ozma, M. A., E. Khodadadi, F. Pakdel, F. S. Kamounah, M. Yousefi, B. Yousefi, M. Asgharzadeh, K. Ganbarov, and H. S. Kafil. 2021. Baicalin, a natural antimicrobial and anti-biofilm agent. Journal of Herbal Medicine 27:100432. doi: 10.1016/j.hermed.2021.100432.
  • Ozma, M. A., E. Khodadadi, M. A. Rezaee, F. S. Kamounah, M. Asgharzadeh, K. Ganbarov, M. Aghazadeh, M. Yousefi, T. Pirzadeh, H. S. Kafil, et al. 2021. Induction of proteome changes involved in biofilm formation of Enterococcus faecalis in response to gentamicin. Microbial Pathogenesis 157:105003. doi: 10.1016/j.micpath.2021.105003.
  • Ozma, M. A., E. Khodadadi, M. A. Rezaee, M. Asgharzadeh, M. Aghazadeh, E. Zeinalzadeh, K. Ganbarov, and H. S. Kafil. 2022. Bacterial proteomics and its application in pathogenesis studies. Current Pharmaceutical Biotechnology 23 (10):1245–56. doi: 10.2174/1389201022666210908153234.
  • Ozma, M. A., J. Rashedi, B. M. Poor, A. Vegari, V. Asgharzadeh, H. S. Kafil, A. Kazemi, L. Sahebi, and M. Asgharzadeh. 2020. Tuberculosis and diabetes mellitus in Northwest of Iran. Infectious Disorders Drug Targets 20 (5):667–71. doi: 10.2174/1871526519666190715142100.
  • Ozma, M. A., M. Lahouty, A. Abbasi, M. A. Rezaee, H. S. Kafil, and M. Asgharzadeh. 2022. Effective bacterial factors involved in the dissemination of tuberculosis.
  • Ozma, M. A., P. Maroufi, E. Khodadadi, Ş. Köse, I. Esposito, K. Ganbarov, et al. 2020. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med 28 (2):153–65.
  • Pachori, P., R. Gothalwal, and P. Gandhi. 2019. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes & Diseases 6 (2):109–19. doi: 10.1016/j.gendis.2019.04.001.
  • Pai, S., Y. Lin, B. Macaes, A. Meneshian, C. Hung, and T. Wu. 2006. Prospects of RNA interference therapy for cancer. Gene Therapy 13 (6):464–77. doi: 10.1038/sj.gt.3302694.
  • Panasevich, M. R., L. Daristotle, R. Quesnell, G. A. Reinhart, and N. Z. Frantz. 2021. Altered fecal microbiota, IgA, and fermentative end-products in adult dogs fed prebiotics and a nonviable Lactobacillus acidophilus. Journal of Animal Science 99 (12):skab347. doi: 10.1093/jas/skab347.
  • Pandey, M., A. Bhati, K. Priya, K. Sharma, and B. Singhal. 2022. Precision postbiotics and mental health: The management of post-COVID-19 complications. Probiotics and Antimicrobial Proteins 14 (3):426–48. doi: 10.1007/s12602-021-09875-4.
  • Parada Venegas, D., M. K. De la Fuente, G. Landskron, M. J. González, R. Quera, G. Dijkstra, H. J. M. Harmsen, K. N. Faber, and M. A. Hermoso. 2019. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology 10:1486. doi: 10.3389/fimmu.2019.01486.
  • Patil, S., S. Sawant, K. Hauff, and G. Hampp. 2019. Validated postbiotic screening confirms presence of physiologically-active metabolites, such as short-chain fatty acids, amino acids and vitamins in Hylak® Forte. Probiotics and Antimicrobial Proteins 11 (4):1124–31. doi: 10.1007/s12602-018-9497-5.
  • Peng, X., A. Ed-Dra, and M. Yue. 2022. Whole genome sequencing for the risk assessment of probiotic lactic acid bacteria. Critical Reviews in Food Science and Nutrition :1–19. doi: 10.1080/10408398.2022.2087174.
  • Pérez, J., A. Moraleda‐Muñoz, F. J. Marcos‐Torres, and J. Muñoz‐Dorado. 2016. Bacterial predation: 75 years and counting!. Environmental Microbiology 18 (3):766–79. doi: 10.1111/1462-2920.13171.
  • Perez-Perez, D. A., T. Villanueva-Ramirez, A. E. Hernandez-Pedraza, N. G. Casillas-Vega, P. Gonzalez-Barranco, and X. Zarate. 2021. The small metal-binding protein SmbP simplifies the recombinant expression and purification of the antimicrobial peptide LL-37. Antibiotics 10 (10):1271. doi: 10.3390/antibiotics10101271.
  • Piccinni, P., M. Dan, S. Barbacini, R. Carraro, E. Lieta, S. Marafon, N. Zamperetti, A. Brendolan, V. D’Intini, C. Tetta, et al. 2006. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Medicine 32 (1):80–6. doi: 10.1007/s00134-005-2815-x.
  • Pires, D. P., L. D. Melo, D. V. Boas, S. Sillankorva, and J. Azeredo. 2017. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Current Opinion in Microbiology 39:48–56. doi: 10.1016/j.mib.2017.09.004.
  • Połaska, M., and B. Sokołowska. 2019. Bacteriophages—A new hope or a huge problem in the food industry. AIMS Microbiology 5 (4):324–46. doi: 10.3934/microbiol.2019.4.324.
  • Pope, W. H., C. A. Bowman, D. A. Russell, D. Jacobs-Sera, D. J. Asai, S. G. Cresawn, W. R. Jacobs, R. W. Hendrix, J. G. Lawrence, G. F. Hatfull, et al. 2015. Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity. eLife 4:e06416. doi: 10.7554/eLife.06416.
  • Prete, R., M. K. Alam, G. Perpetuini, C. Perla, P. Pittia, and A. Corsetti. 2021. Lactic acid bacteria exopolysaccharides producers: A sustainable tool for functional foods. Foods 10 (7):1653. doi: 10.3390/foods10071653.
  • Rad, A. H., A. Abbasi, H. S. Kafil, and K. Ganbarov. 2020. Potential pharmaceutical and food applications of postbiotics: A review. Current Pharmaceutical Biotechnology 21 (15):1576–87. doi: 10.2174/1389201021666200516154833.
  • Rad, A. H., L. A. Maleki, H. S. Kafil, H. F. Zavoshti, and A. Abbasi. 2020. Postbiotics as novel health-promoting ingredients in functional foods. Health Promotion Perspectives 10 (1):3–4. doi: 10.15171/hpp.2020.02.
  • Rad, A. H., L. A. Maleki, H. S. Kafil, H. F. Zavoshti, and A. Abbasi. 2021. Postbiotics as promising tools for cancer adjuvant therapy. Advanced Pharmaceutical Bulletin 11 (1):1.
  • Rad, A. H., L. Aghebati-Maleki, H. S. Kafil, and A. Abbasi. 2021. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment. Critical Reviews in Food Science and Nutrition 61 (11):1787–803. doi: 10.1080/10408398.2020.1765310.
  • Raknam, P., N. Balekar, R. Teanpaisan, and T. Amnuaikit. 2022. Thermoresponsive sol–gel containing probiotic’s cell free supernatant for dental caries prophylaxis. Journal of Oral Microbiology 14 (1):2012390. doi: 10.1080/20002297.2021.2012390.
  • Rasmussen, T. B., and M. Givskov. 2006. Quorum sensing inhibitors: A bargain of effects. Microbiology (Reading, England) 152 (Pt 4):895–904. doi: 10.1099/mic.0.28601-0.
  • Ratanarat, R., A. Brendolan, P. Piccinni, M. Dan, G. Salvatori, Z. Ricci, and C. Ronco. 2005. Pulse high-volume haemofiltration for treatment of severe sepsis: Effects on hemodynamics and survival. Critical Care 9 (4):R294. doi: 10.1186/cc3529.
  • Ravindran, A., G. S. Kiran, and J. Selvin. 2022. Revealing the effect of lipopeptide on improving the probiotics characteristics: Flavor and texture enhancer in the formulated yogurt. Food Chemistry 375:131718. doi: 10.1016/j.foodchem.2021.131718.
  • Reque, P. M., and A. Brandelli. 2021. Encapsulation of probiotics and nutraceuticals: Applications in functional food industry. Trends in Food Science & Technology 114:1–10. doi: 10.1016/j.tifs.2021.05.022.
  • Ribas, A., and J. D. Wolchok. 2018. Cancer immunotherapy using checkpoint blockade. Science (New York, N.Y.) 359 (6382):1350–5. doi: 10.1126/science.aar4060.
  • Riwes, M., and P. Reddy, editors. 2020. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 57 (1):1–6. doi: 10.1053/j.seminhematol.2020.06.001.
  • Rodríguez-Daza, M. C., E. C. Pulido-Mateos, J. Lupien-Meilleur, D. Guyonnet, Y. Desjardins, and D. Roy. 2021. Polyphenol-mediated gut microbiota modulation: Toward prebiotics and further. Frontiers in Nutrition 8:689456. doi: 10.3389/fnut.2021.689456.
  • Rotem, O., Z. Pasternak, E. Shimoni, E. Belausov, Z. Porat, S. Pietrokovski, and E. Jurkevitch. 2015. Cell-cycle progress in obligate predatory bacteria is dependent upon sequential sensing of prey recognition and prey quality cues. Proceedings of the National Academy of Sciences of the United States of America 112 (44):E6028–E6037. doi: 10.1073/pnas.1515749112.
  • Roth, G. A., V. C. Picece, B. S. Ou, W. Luo, B. Pulendran, and E. A. Appel. 2022. Designing spatial and temporal control of vaccine responses. Nature Reviews. Materials 7 (3):174–95. doi: 10.1038/s41578-021-00372-2.
  • Ryan, E. M., S. P. Gorman, R. F. Donnelly, and B. F. Gilmore. 2011. Recent advances in bacteriophage therapy: How delivery routes, formulation, concentration and timing influence the success of phage therapy. The Journal of Pharmacy and Pharmacology 63 (10):1253–64. doi: 10.1111/j.2042-7158.2011.01324.x.
  • Sabahi, S., A. Homayouni Rad, L. Aghebati-Maleki, N. Sangtarash, M. A. Ozma, A. Karimi, H. Hosseini, and A. Abbasi. 2022. Postbiotics as the new frontier in food and pharmaceutical research. Critical Reviews in Food Science and Nutrition :1–28. doi: 10.1080/10408398.2022.2056727.
  • Sangro, B., P. Sarobe, S. Hervás-Stubbs, and I. Melero. 2021. Advances in immunotherapy for hepatocellular carcinoma. Nature Reviews. Gastroenterology & Hepatology 18 (8):525–43. doi: 10.1038/s41575-021-00438-0.
  • Savoia, D. 2012. Plant-derived antimicrobial compounds: Alternatives to antibiotics. Future Microbiology 7 (8):979–90. doi: 10.2217/fmb.12.68.
  • Scarpellini, E., E. Rinninella, M. Basilico, E. Colomier, C. Rasetti, T. Larussa, P. Santori, and L. Abenavoli. 2021. From pre-and probiotics to post-biotics: A narrative review. International Journal of Environmental Research and Public Health 19 (1):37. doi: 10.3390/ijerph19010037.
  • Sharma, A., V. K. Gupta, and R. Pathania. 2019. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. The Indian Journal of Medical Research 149 (2):129–45. doi: 10.4103/ijmr.IJMR_2079_17.
  • Shriwas, O., P. Mohapatra, S. Mohanty, and R. Dash. 2020. The impact of m6A RNA modification in therapy resistance of cancer: Implication in chemotherapy, radiotherapy, and immunotherapy. Frontiers in Oncology 10:612337. doi: 10.3389/fonc.2020.612337.
  • Silpe, J. E., and B. L. Bassler. 2019. A host-produced quorum-sensing autoinducer controls a phage lysis-lysogeny decision. Cell 176 (1-2):268–80. e13. doi: 10.1016/j.cell.2018.10.059.
  • Silva, A. R., C. Grosso, C. Delerue-Matos, and J. M. Rocha. 2019. Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity. European Journal of Medicinal Chemistry 174:87–115. doi: 10.1016/j.ejmech.2019.04.028.
  • Singh, P., E. J. Alm, J. M. Kelley, V. Cheng, M. Smith, Z. Kassam, J. Nee, J. Iturrino, and A. Lembo. 2022. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes 14 (1):2020067. doi: 10.1080/19490976.2021.2020067.
  • Singh, R., N. Capalash, and P. Sharma. 2022. Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: A systematic review. 3 Biotech 12 (3):1–14. doi: 10.1007/s13205-022-03148-9.
  • Smith, E. S., E. Whitty, B. Yoo, A. Moore, L. F. Sempere, and Z. Medarova. 2022. Clinical applications of short non-coding RNA-based therapies in the era of precision medicine. Cancers 14 (6):1588. doi: 10.3390/cancers14061588.
  • Smith, M., A. Dai, G. Ghilardi, K. Amelsberg, S. M. Devlin, R. Pajarillo, J. B. Slingerland, S. Beghi, P. S. Herrera, P. A. Giardina, et al. 2021. The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies. Blood 138 (Supplement 1):253– doi: 10.1182/blood-2021-153945.
  • Spagnolello, O., C. Pinacchio, L. Santinelli, P. Vassalini, G. P. Innocenti, G. De Girolamo, S. Fabris, M. Giovanetti, S. Angeletti, A. Russo, et al. 2021. Targeting microbiome: An alternative strategy for fighting SARS-CoV-2 infection. Chemotherapy 66 (1-2):24–32. doi: 10.1159/000515344.
  • Stan, D., A.-M. Enciu, A. L. Mateescu, A. C. Ion, A. C. Brezeanu, D. Stan, and C. Tanase. 2021. Natural compounds with antimicrobial and antiviral effect and nanocarriers used for their transportation. Frontiers in Pharmacology 12:2405. doi: 10.3389/fphar.2021.723233.
  • Staniszewski, A., and M. Kordowska-Wiater. 2021. Probiotic and potentially probiotic yeasts—Characteristics and food application. Foods 10 (6):1306. doi: 10.3390/foods10061306.
  • Suleiman, L., C. Négrier, and H. Boukerche. 2013. Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Critical Reviews in Oncology/Hematology 88 (3):637–54. doi: 10.1016/j.critrevonc.2013.07.004.
  • Sundaram, P., H. Kurniawan, M. E. Byrne, and J. Wower. 2013. Therapeutic RNA aptamers in clinical trials. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 48 (1-2):259–71. doi: 10.1016/j.ejps.2012.10.014.
  • Sutcliffe, S. G., A. Reyes, and C. F. Maurice. 2023. Bacteriophages playing nice: Lysogenic bacteriophage replication stable in the human gut microbiota. bioRxiv 26 (2):106007
  • Szlufman, C., and M. Shemesh. 2021. Role of probiotic Bacilli in developing synbiotic food: Challenges and opportunities. Frontiers in Microbiology 12:638830. doi: 10.3389/fmicb.2021.638830.
  • Tankersley, M., J. K. Han, and H. Nolte. 2020. Clinical aspects of sublingual immunotherapy tablets and drops. Annals of Allergy, Asthma & Immunology: Official Publication of the American College of Allergy, Asthma, & Immunology 124 (6):573–82. doi: 10.1016/j.anai.2019.12.025.
  • Teame, T., A. Wang, M. Xie, Z. Zhang, Y. Yang, Q. Ding, C. Gao, R. E. Olsen, C. Ran, Z. Zhou, et al. 2020. Paraprobiotics and postbiotics of probiotic lactobacilli, their positive effects on the host and action mechanisms: A review. Frontiers in Nutrition 7:570344. doi: 10.3389/fnut.2020.570344.
  • Thite, S., Y. Chavan, V. Aparadh, and B. Kore. 2013. Preliminary phytochemical screening of some medicinal plants. International Journal of Pharmaceutical, Chemical and Biological Sciences 3 (1):87–90.
  • Till, S. J., J. N. Francis, K. Nouri-Aria, and S. R. Durham. 2004. Mechanisms of immunotherapy. The Journal of Allergy and Clinical Immunology 113 (6):1025–34; quiz 1035. doi: 10.1016/j.jaci.2004.03.024.
  • Tridgett, M., M. Ababi, andA. Jaramillo. 2022. Lambda Red Recombineering of Bacteriophage in the Lysogenic State. Methods in Molecular Biology (Clifton, N.J.) 2479:11–9. doi: 10.1007/978-1-0716-2233-9_2. 35583729
  • Tse, B. W.-C., A. Collins, M. Oehler, A. Zippelius, and V. Heinzelmann-Schwarz. 2014. Antibody-based immunotherapy for ovarian cancer: Where are we at? Annals of Oncology: Official Journal of the European Society for Medical Oncology 25 (2):322–31. doi: 10.1093/annonc/mdt405.
  • Tzialla, C., A. Borghesi, G. Perotti, F. Garofoli, P. Manzoni, and M. Stronati. 2012. Use and misuse of antibiotics in the neonatal intensive care unit. The Journal of Maternal-Fetal & Neonatal Medicine 25 (sup4):27–9. doi: 10.3109/14767058.2012.714987.
  • van Driel, M. L., G. Merlo, E. Baillie, J. Dartnell, L. Hall, and C. Heal. 2022. Preserving antibiotics for the future. Australian Journal of General Practice 51 (1-2):10–3. doi: 10.31128/AJGP-08-21-6144.
  • Walkenhorst, W. F. 2016. Using adjuvants and environmental factors to modulate the activity of antimicrobial peptides. Biochimica et Biophysica Acta 1858 (5):926–35. doi: 10.1016/j.bbamem.2015.12.034.
  • Wang, W., X. Luo, X. Ye, Y. Chen, H. Wang, L. Wang, Y. Wang, Y. Yang, Z. Li, H. Cao, et al. 2020. Predatory Myxococcales are widely distributed in and closely correlated with the bacterial community structure of agricultural land. Applied Soil Ecology 146:103365. doi: 10.1016/j.apsoil.2019.103365.
  • Wang, Y., J. Lu, S. Zhang, J. Li, L. Mao, Z. Yuan, P. L. Bond, and J. Guo. 2021. Non-antibiotic pharmaceuticals promote the transmission of multidrug resistance plasmids through intra-and intergenera conjugation. The ISME Journal 15 (9):2493–508. doi: 10.1038/s41396-021-00945-7.
  • Wang, Z., X. Liu, Y. Peng, M. Su, S. Zhu, J. Pan, B. Shen, Y. Duan, and Y. Huang. 2020. Platensimycin-encapsulated liposomes or micelles as biosafe nanoantibiotics exhibited strong antibacterial activities against methicillin-resistant Staphylococcus aureus infection in mice. Molecular Pharmaceutics 17 (7):2451–62. doi: 10.1021/acs.molpharmaceut.0c00194.
  • Weledji, E. P., E. K. Weledji, J. C. Assob, and D. S. Nsagha. 2017. Pros, cons and future of antibiotics. New Horizons in Translational Medicine 4 (1-4):9–14. doi: 10.1016/j.nhtm.2017.08.001.
  • White, C. A., R. L. Weaver, and A. J. Grillo-López. 2001. Antibody-targeted immunotherapy for treatment of malignancy. Annual Review of Medicine 52 (1):125–45. doi: 10.1146/annurev.med.52.1.125.
  • White, J. M., F. E. Escorcia, and N. T. Viola. 2021. Perspectives on metals-based radioimmunotherapy (RIT): Moving forward. Theranostics 11 (13):6293–314. doi: 10.7150/thno.57177.
  • Wigner, P., M. Bijak, and J. Saluk-Bijak. 2022. Probiotics in the prevention of the calcium oxalate urolithiasis. Cells 11 (2):284. doi: 10.3390/cells11020284.
  • Wilkins, T., and J. Sequoia. 2017. Probiotics for gastrointestinal conditions: A summary of the evidence. American Family Physician 96 (3):170–8.
  • Wilson, D. N., V. Hauryliuk, G. C. Atkinson, and A. J. O’Neill. 2020. Target protection as a key antibiotic resistance mechanism. Nature Reviews. Microbiology 18 (11):637–48. doi: 10.1038/s41579-020-0386-z.
  • Wu, H., and J. Chiou. 2021. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients 13 (8):2878. doi: 10.3390/nu13082878.
  • Wu, J., Y. Zhang, L. Ye, and C. Wang. 2021. The anti-cancer effects and mechanisms of lactic acid bacteria exopolysaccharides in vitro: A review. Carbohydrate Polymers 253:117308. doi: 10.1016/j.carbpol.2020.117308.
  • Yap, T. A., E. E. Parkes, W. Peng, J. T. Moyers, M. A. Curran, and H. A. Tawbi. 2021. Development of immunotherapy combination strategies in cancerimmunotherapy combination strategies in cancer. Cancer Discovery 11 (6):1368–97. doi: 10.1158/2159-8290.CD-20-1209.
  • Yu, Z., Y. Wang, J. Lu, P. L. Bond, and J. Guo. 2021. Nonnutritive sweeteners can promote the dissemination of antibiotic resistance through conjugative gene transfer. The ISME Journal 15 (7):2117–30. doi: 10.1038/s41396-021-00909-x.
  • Zakataeva, N. P. 2021. Microbial 5′-nucleotidases: Their characteristics, roles in cellular metabolism, and possible practical applications. Applied Microbiology and Biotechnology 105 (20):7661–81. doi: 10.1007/s00253-021-11547-w.
  • Zhang, Y., L. Wang, J. Zhang, Y. Li, Q. He, H. Li, X. Guo, J. Guo, and H. Zhang. 2014. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. European Journal of Nutrition 53 (1):221–32. doi: 10.1007/s00394-013-0519-5.
  • Zhou, J., M. L. Bobbin, J. C. Burnett, and J. J. Rossi. 2012. Current progress of RNA aptamer-based therapeutics. Frontiers in Genetics 3:234. doi: 10.3389/fgene.2012.00234.
  • Zhu, M., M. W. Tse, J. Weller, J. Chen, and P. C. Blainey. 2021. The future of antibiotics begins with discovering new combinations. Annals of the New York Academy of Sciences 1496 (1):82–96. doi: 10.1111/nyas.14649.
  • Zhu, S., T. Zhang, L. Zheng, H. Liu, W. Song, D. Liu, Z. Li, and C-x Pan. 2021. Combination strategies to maximize the benefits of cancer immunotherapy. Journal of Hematology & Oncology 14 (1):1–33. doi: 10.1186/s13045-021-01164-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.